Intra-nigral MPTP lesion in rats:: Behavioral and autoradiography studies

被引:22
作者
Perry, JC
Hipólide, DC
Tufik, S
Martins, RD
Da Cunha, C
Andreatini, R
Vital, MABF
机构
[1] Univ Fed Parana, Setor Ciencias Biol, Dept Farmacol, BR-81531990 Curitiba, Parana, Brazil
[2] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
MPTP; Parkinson's disease; motor activity; rat; dopamine; D-1; D-2;
D O I
10.1016/j.expneurol.2005.05.009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study investigated the motor response and possible changes in binding to D-1 and D-2 receptors after intra-nigral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) infusion on rats. The results indicated that MPTP-lesioned rats exhibited a significant reduction in locomotion and rearing frequencies observed in an open field 24 h after surgery. However, at 7 and 14 days after surgery the MPTP-lesioned rats showed a significant increase in locomotion in comparison to the control groups, as well as a decrease in immobility time. In addition, 21 days after surgery the behavioral measurements were unaltered by these procedures. Moreover, latency in initiating movement and catalepsy were unchanged by this neurotoxin on the same days of observation. An autoradiography approach indicated that there was a reduction in [H-3]SCH 23390 binding in substantia nigra pars compacta (SNpc), substantia nigra pars reticulata (SNpr) and ventrolateral striatum in MPTP-treated rats 21 days after the surgery. [H-3]raclopride binding remained unaltered by the MPTP treatment. These results suggest that compensatory plastic changes occur in D I dopamine receptors after partial lesion of nigral dopaminergic neurons. These alterations might be related to the occurrence and recovery of motor impairment observed in MPTP-lesioned rats. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:322 / 329
页数:8
相关论文
共 50 条
[1]   CHANGES IN BRAIN DOPAMINE-RECEPTORS IN MPTP PARKINSONIAN MONKEYS FOLLOWING L-DOPA TREATMENT [J].
ALEXANDER, GM ;
SCHWARTZMAN, RJ ;
GROTHUSEN, JR ;
BRAINARD, L ;
GORDON, SW .
BRAIN RESEARCH, 1993, 625 (02) :276-282
[2]  
ANDERSEN ML, 2004, ETHICAL PRACTICAL PR, P45
[3]   Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse [J].
Araki, T ;
Mikami, T ;
Tanji, H ;
Matsubara, M ;
Imai, Y ;
Mizugaki, M ;
Itoyama, Y .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 12 (03) :231-238
[4]   PARKINSONIAN-LIKE LOCOMOTOR IMPAIRMENT IN MICE LACKING DOPAMINE D2 RECEPTORS [J].
BAIK, JH ;
PICETTI, R ;
SAIARDI, A ;
THIRIET, G ;
DIERICH, A ;
DEPAULIS, A ;
LEMEUR, M ;
BORRELLI, E .
NATURE, 1995, 377 (6548) :424-428
[5]   Lesion of the substantia nigra, pars compacta impairs delayed alternation in a Y-maze in rats [J].
Braga, R ;
Kouzmine, I ;
Canteras, NS ;
Da Cunha, C .
EXPERIMENTAL NEUROLOGY, 2005, 192 (01) :134-141
[6]  
BROADHURST PL, 1960, EXPT PERSONALITY
[7]   STRIATAL D2 RECEPTOR STATUS IN PATIENTS WITH PARKINSONS-DISEASE, STRIATONIGRAL DEGENERATION, AND PROGRESSIVE SUPRANUCLEAR PALSY, MEASURED WITH C-11 RACLOPRIDE AND POSITRON EMISSION TOMOGRAPHY [J].
BROOKS, DJ ;
IBANEZ, V ;
SAWLE, GV ;
PLAYFORD, ED ;
QUINN, N ;
MATHIAS, CJ ;
LEES, AJ ;
MARSDEN, CD ;
BANNISTER, R ;
FRACKOWIAK, RSJ .
ANNALS OF NEUROLOGY, 1992, 31 (02) :184-192
[8]   DOPAMINE-D1 AND DOPAMINE-D2 RECEPTORS VISUALIZED IN MPTP TREATED C57 MICE BY INVITRO AUTORADIOGRAPHY - LACK OF EVIDENCE OF RECEPTOR MODIFICATIONS IN PARKINSONIAN MICE [J].
CAMPS, M ;
AMBROSIO, S ;
BALLARIN, M ;
REIRIZ, J ;
BLESA, R ;
MAHY, N .
PHARMACOLOGY & TOXICOLOGY, 1989, 65 (03) :169-174
[9]   METABOLISM OF THE NEUROTOXIC TERTIARY AMINE, MPTP, BY BRAIN MONOAMINE-OXIDASE [J].
CHIBA, K ;
TREVOR, A ;
CASTAGNOLI, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (02) :574-578
[10]   DOPAMINE-RECEPTORS IN HUMAN-BRAIN - AUTORADIOGRAPHIC DISTRIBUTION OF D1 AND D2 SITES IN PARKINSON SYNDROME OF DIFFERENT ETIOLOGY [J].
CORTES, R ;
CAMPS, M ;
GUEYE, B ;
PROBST, A ;
PALACIOS, JM .
BRAIN RESEARCH, 1989, 483 (01) :30-38